Guarnieri, C. (2016). Case study of a young adult with Ewing sarcoma. Journal of Advanced Practice Oncology, 7, 634–638. doi:10.6004/ jadpro.2016.7.6.5 Harada, H. (2011). How can we overcome tumor hypoxia in radiation therapy ? Journal of Radiation Research, 52 (5), 545–556. doi:10.1269/ jrr.11056 Hartwell, L. H. e Kastan, M. B. (1994). Cell cycle control and cancer. Science, 266 (5192), 1821–1828. doi:10.1126/science.7997877 Hawkins, D. S., Brennan, B. M. D., Bolling, T., Davidson, D. J., Dirksen, U., DuBois, S., . . . Lessnick, S. L. (2016). Ewing sarcoma. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 855-876). Filadélfia, PA: Wolters Kluwer. Heerema-McKenney, A., Cleary, M. L. e Arber, D. A. (2016). Pathology and molecular diagnosis of leukemias and lymphomas. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 113-130). Filadélfia, PA: Wolters Kluwer. Heynick, F. (2009). The original “magic bullet” is 100 years old—extra. British Journal of Psychiatry, 195 (5), 456. doi:10.1192/bjp.195.5.456 Hoehn, D. e Loghavi, S. (2014). Laboratory techniques used in the diagnosis of pediatric tumors. In D. M. Parham, J. D. Khoury e M. B. McCarville (Eds.), Pediatric malignancies: Pathology and imaging (pp. 1–5). Nova York, NY: Springer Science and Business. Hoff, C. M., Hansen, H. S., Overgaard, M., Grau, C., Johansen, J., Bentzen, J. e Overgaard, J. (2011). The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy: Results from the randomized DAHANCA 5 study. Radiotherapy Oncology, 98 (1), 28–33. doi:10.1016/j. radonc.2010.09.024 Hooke, M. C., Baggott, C., Robinson, D., Woolery, M., Maloney, A. M., Dulczak, S. e Madsen, L. (2011). Managing disease- and treatment- related complications in pediatric oncology. In C. Baggott, D. Fochtman, G. V. Foley e K. P. Kelly (Eds.), Nursing care of children and adolescents with cancer and blood disorders (4 a ed., pp. 549– 550). Glenview, IL: Association of Pediatric Hematology/Oncology Nursing. Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N. e Sarkar, S. (2014). Drug resistance in cancer: An overview. Cancer, 6 (3), 176901792. doi:10.3390/cancers6031769 Howlader, N., Noone, A. M., Krapcho, M., Miller, D., Bishop, K., Kosary, C. L., . . . Cronin, K. A. (Eds.). (2017). SEER cancer statistics review, 1975–2014 . Bethesda, MD: National Cancer Institute. Extraído de: https://seer.cancer.gov/csr/1975_2014/, baseado em envio de dados da SEER em novembro de 2016, publicado no site da SEER em abril de 2017. Hurwitz, R. L. Shields, C. L., Shields, J. A., Chevez-Barrios, P., Gombos, D. S., Hurwitz, M. Y. e Chintagumpala, M. M. (2016). Retinoblastoma. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 700-725). Filadélfia, PA: Wolters Kluwer. Iqbal, N. e Iqbal, N. (2014). Imatinib: A breakthrough of targeted therapy in cancer. Chemotherapy Research and Practice, 2014, 357027. doi:10.1155/2014/357027 Ivanovska, V., Rademaker, C. M. A., van Dijk, L. e Mantel-Teeuwisse, A. K. (2014). Pediatric drug formulations: A review of challenges and progress. Pediatrics, 134 (2), 361–372. doi:10.1542/peds.2013-3225 Johnson, G. B. (2007). Cancer diagnosis and staging. Em M. E. Langhorne, J. S. Fulton e S. E. Otto (Eds.), Oncology nursing (5 a ed., pp. 70–78). St. Louis, MO: Mosby. Karnofsky, D. A. e Burchenal, J. H. (1949). The clinical evaluation of chemotherapeutic agents in cancer. Em C. M. MacLeod (Ed.). Evaluation of chemotherapeutic agents (pp. 191–205). Nova York, NY: Columbia University Press. Kearns, G. L., Abdel-Rahman, S. M., Alander, S. W., Blowey, D. L., Leeder, J. S. e Kauffman, R. E. (2003). Developmental pharmacology: Drug disposition, action and therapy in infants and children. The New England Journal of Medicine, 349 (12), 1157–1167. doi:10.1056/ NEJMra035092
Krishnamurthy, R., Daldrup-Link, H. E., Jones, J. Y., Voss, S. D., Khanna, G., Golriz, F. e Guillerman, R. P. (2016). Imaging studies in the diagnosis and management of pediatric malignancies. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 185-238). Filadélfia, PA: Wolters Kluwer. Lafond, D. A., Bolton, R. M. e Mannix, C. M. (2011). Radiation therapy. Em C. Baggott, D. Fochtman, G. V. Foley e K. P. Kelly (Eds.), Nursing care of children and adolescents with cancer and blood disorders (4 a ed., pp. 296-325). Glenview, IL: Association of Pediatric Hematology/ Oncology Nurses. Lansky, S. B., List, M. A., Lansky, L. L., Ritter-Sterr, C. e Miller, D.R. (1987). The measurement of performance in childhood cancer patients. Cancer, 60 (7), 1651–1656. doi:10.1002/1097- 0142(19871001)60:7<1651::AID-CNCR2820600738>3.0.CO;2-J LeFebvre, K. B. e Stiver, W. (2014). Overview of cancer and cancer treatment. Em M. Polovich, M. Olsen e K. B. LeFebvre (Eds.), Chemotherapy and biotherapy guidelines and recommendations for practice (4 a ed., pp. 1–16). Pittsburgh, PA: Oncology Nurses Society. Leonard, M. (2011). Nursing implications of diagnostic and staging procedures. In C. Baggott, D. Fochtman, G. V. Foley e K. P. Kelly (Eds.), Nursing care of children and adolescents with cancer and blood disorders (4 a ed., pp. 236-267). Filadélfia, PA: W.B. Saunders. MacDonald, S. M. e Marcus, K. J. (2015). Pediatric radiation oncology. Em S. H. Orkin, D. E. Fisher, D. Ginsburg, A. T. Look, S. E. Lux e D. G. Nathan (Eds.), Nathan and Oski’s hematology and oncology of infancy and childhood (8 a ed., pp. 1474–1488). Filadélfia, PA: Elsevier. Madadi, P., Amstutz, U., Rieder, M., Ito, S., Fung, V., Hwang, S., . . . Carleton, B. C., CPNDS Clinical Recommendations Group. (2013). Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapy. Journal of Population Therapeutics and Clinical Pharmacology, 20 (3), e369–396. Maroney, A. C. (2013). Pharmacodynamics. Em Merck manual, professional version . Extraído de: http://www.merckmanuals.com/ professional/clinical-pharmacology/pharmacodynamics McCarville, M. B. (2014). Imaging techniques used in diagnostic pediatric tumors. In D. M. Parham, J. D. Khoury e M. B. McCarville (Eds.), Pediatric malignancies: Pathology and imaging (pp. 7-19). Nova York, NY: Springer Science and Business. Merkle, C. J. (2011). Biology of cancer. Em C. H. Yarbro, D. Wujcik e B. H. Gobel (Eds.), Cancer nursing: Principles and practice (7 a ed., pp. 3–22). Sudbury, MA: Jones and Bartlett. Metzger, M. L., Krastin, M. J., Choi, J. K. e Hudson, M. M. (2016). Hodgkin lymphoma. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 568-586). Filadélfia, PA: Wolters Kluwer. Meyers, R. L., Trobaugh-Lotrario, A. D., Malogolowkin, M. H., Katzenstein, H. M., Lopez-Terrada, D. H. e Finegold, M. J. (2016). Liver tumors. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 726-752). Filadélfia, PA: Wolters Kluwer. Muehlbauer, P. M., Shelburne, N. e Shields, S. (2014). Principles of antineoplastic therapy. Em M. Polovich, M. Olsen e K. B. LeFebvre (Eds.), Chemotherapy and biotherapy guidelines and recommendations for practice (4 a ed., pp. 25-50). Pittsburgh, PA: Oncology Nursing Society. Muehlbauer, P. M., Shelburne, N. e Steinberg, M. (2014). Principles of biotherapy. Em M. Polovich, M. Olson e K. B. LeFebvre (Eds.), Chemotherapy and biotherapy guidelines and recommendations for practice (4 a ed., pp. 51–96). Pittsburgh, PA: Oncology Nursing Society. National Cancer Institute (NCI). (15 de agosto de 2014). Targeted therapy. Extraído de: http://www.cancer.gov/about-cancer/treatment/ types/targeted-therapies
37
Capítulo 2. Visão Geral do Câncer
Powered by FlippingBook